The new CurvaFix IM Implant will provide strong, stable, curved fixation in small-boned patients. Credit: CurvaFix, Inc / Business Wire.

Medical devices maker CurvaFix has introduced a new 7.5mm intramedullary device to simplify surgery and enable stable fixation in small-boned patients.

Named CurvaFix IM Implant, the smaller-diameter device will be showcased at the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting in Las Vegas, Nevada, US.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The firm will also showcase the 9.5mm CurvaFix Implant at the event, which is being held from March 7 to 11.

According to the University of Missouri Orthopaedic Trauma Service and Orthopaedic Trauma Fellowship director Dr Brett Crist, the new 7.5mm CurvaFix device can be used for both left and right rami nonunions.

So far, the CurvaFix procedure has been used to treat more than 175 patients, including over 100 patients who are either geriatric and/or suffer from fragility fractures of the pelvis (FFP), stated the company.

CurvaFix Implants are said to offer potential benefits in different pelvic injuries and conditions, including polytrauma patients who have multiple complex injuries, FFP patients with weak bone and those with dysmorphic bony anatomy.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It is also said to be beneficial in revision surgery for failed pelvic fracture fixation, for oncology patients with pelvic fractures, and for patients with impeding total hip or lumbosacral spinal hardware.

CurvaFix CEO Steve Dimmer said: “The new 7.5mm device is designed to simplify surgery and provide strong, stable, curved fixation in smaller patients.

“Additionally, our novel device has been shown to offer many geriatric patients immediate pain relief and early mobility, which is critically important in older patients, where mobility is such a key to life.”